Clinical Trial Update: A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

This document reports an update on a Phase 1 study evaluating CP-675,206 in combination with gemcitabine in patients with previously untreated, advanced pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CP-675,206
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: AstraZeneca | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED